[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338015-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338015-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ultrasound-imaging-in-active-surveillance-of-small-low-risk-papillary-thyroid-cancer","Ultrasound Imaging in Active Surveillance of Small, Low-Risk Papillary Thyroid Cancer","","Ultrasound imaging supports active surveillance as a less invasive management strategy for small, low-risk papillary thyroid cancer, aiming to limit overdiagnosis and overtreatment. The article summarizes progression rates reported for cancers ≤1 cm and discusses ongoing efforts to extend feasibility to larger tumors. It details surveillance protocols emphasizing standardized ultrasound assessment, monitoring nodule size, growth, extrathyroidal extension, and proximity to the trachea and recurrent laryngeal nerve, plus possible nodal metastases.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ultrasound-imaging-in-active-surveillance-of-small-low-risk-papillary-thyroid-cancer/338015/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ultrasound-imaging-in-active-surveillance-of-small-low-risk-papillary-thyroid-cancer/338015.png","ImageObject",300,407,{"name":42,"@type":43},"Oliver","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-09","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is active surveillance used for small, low-risk papillary thyroid cancer?","Question",{"text":63,"@type":64},"Active surveillance is used to avoid unnecessary interventions and their risks when the likelihood of disease progression is low, particularly for incidentally discovered small PTCs.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What does an active surveillance ultrasound protocol typically monitor?",{"text":68,"@type":64},"Protocols emphasize standardized ultrasound assessment and monitoring for changes in maximal diameter, growth, possible extrathyroidal extension, proximity to the trachea and recurrent laryngeal nerve, and potential cervical nodal metastases.",{"name":70,"@type":61,"acceptedAnswer":71},"How is disease progression commonly defined during active surveillance?",{"text":72,"@type":64},"Progression is often defined by an increase in the maximum diameter of the PTC, along with related evaluation of sonographic features during follow-up.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338015,1790176087,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":107,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Focus | Thyroid  \neISSN 2005-8330  \n[https://doi.org/10.3348/kjr.2024.0148](https://doi.org/10.3348/kjr.2024.0148)[ ](https://doi.org/10.3348/kjr.2024.0148)[Korean J Radiol 2024](Korean J Radiol 2024);[25](25)([8](8))[:749-755](:749-755)  \nUltrasound Imaging in Active Surveillance of Small, Low-Risk Papillary Thyroid Cancer  \nSangeet Ghai1, David P Goldstein2, Anna M Sawka3  \n1Joint Department of Medical Imaging, University Health Network–Mount Sinai Hospital–Women’s College Hospital, University of Toronto, Toronto, Canada  \n2 Department of Otolaryngology-Head and Neck Surgery/Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada  \n3 Division of Endocrinology, Department of Medicine, University Health Network and University of Toronto, Toronto, Canada  \nThe recent surge in the incidence of small papillary thyroid cancers (PTCs) has been linked to the widespread use of ultrasonography, thereby prompting concerns regarding overdiagnosis. Active surveillance (AS) has emerged as a less invasive alternative management strategy for low-risk PTCs, especially for PTCs measuring ≤1 cm in maximal diameter. Recent studies report low disease progression rates of low-risk PTCs ≤1 cm under AS. Ongoing research is currently exploring the feasibility of AS for larger PTCs (\u003C20 mm). AS protocols include meticulous ultrasound assessment, emphasis on standardized techniques, and a multidisciplinary approach; they involve monitoring the nodules for size, growth, potential extrathyroidal extension, proximity to the trachea and recurrent laryngeal nerve, and potential cervical nodal metastases. The criteria for progression, often defined as an increase in the maximum diameter of the PTC, warrant a review of precision and ongoing examinations. Challenges exist regarding the reliability of volume measurements for defining PTC disease progression. Although ultrasonography plays a pivotal role, challenges in assessing progression and minor extrathyroidal extension underscore the importance of a multidisciplinary approach in disease management. This comprehensive overview highlights the evolving landscape of AS for PTCs, emphasizing the need for standardized protocols, meticulous assessments, and ongoing research to inform decision-making. Keywords: Thyroid; Papillary thyroid cancer; Active surveillance; Ultrasound; Outcomes  \nINTRODUCTION  \nThe recent rapid increase in the incidence of small papillary thyroid cancers (PTCs) has been attributed to the worldwide increased use of diagnostic technologies (including ultrasonography), which have lead to the overdiagnosis of indolent PTCs. North American clinical practice guidelines generally do not recommend biopsy of thyroid nodules \u003C1 cm and instead recommend ultrasound  \nReceived: February 8, 2024 Revised: May 9, 2024  \nAccepted: May 11, 2024  \nCorresponding author: Sangeet Ghai, MD, Joint Department of Medical Imaging, University Health Network–Mount Sinai Hospital– Women’s College Hospital, University of Toronto, 1PMB-292, 585 University Avenue, Toronto, ON M5G 2N2, Canada  \n• E-mail: [sangeet.ghai@uhn.ca](sangeet.ghai@uhn.ca)  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ([https://creativecommons.org/licenses/by-nc/4.0](https://creativecommons.org/licenses/by-nc/4.0)) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nmonitoring, regardless of the presence of suspicious sonographic features [1,2] . Patients with suspicious subcentimeter nodules may undergo active surveillance (AS) . A recent study by Kim et al. [3] showed that highly suspicious nodules on ultrasound measuring ≤10 mm in maximal diameter without fine needle aspiration biopsy, had a low disease progression rate over a median followup period of 4.8 years. The rationale for the use of AS is to avoid unnecessary inter","cbCaicmjofFs7NcW","https://ap.wps.com/l/cbCaicmjofFs7NcW","pdf",1083317,"English","# Introduction\n# Active Surveillance Protocols and Ultrasound Assessment\n## Monitoring Targets and Progression Criteria\n## Challenges in Volume Measurement","[{\"question\":\"Why is active surveillance used for small, low-risk papillary thyroid cancer?\",\"answer\":\"Active surveillance is used to avoid unnecessary interventions and their risks when the likelihood of disease progression is low, particularly for incidentally discovered small PTCs.\"},{\"question\":\"What does an active surveillance ultrasound protocol typically monitor?\",\"answer\":\"Protocols emphasize standardized ultrasound assessment and monitoring for changes in maximal diameter, growth, possible extrathyroidal extension, proximity to the trachea and recurrent laryngeal nerve, and potential cervical nodal metastases.\"},{\"question\":\"How is disease progression commonly defined during active surveillance?\",\"answer\":\"Progression is often defined by an increase in the maximum diameter of the PTC, along with related evaluation of sonographic features during follow-up.\"}]","Ultrasound Imaging in Active Surveillance of Small, Low-Risk Papillary Thyroid Cancer | PDF",1790021586,18,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5ba2676afe96bf3ccc1b3b5849b9671.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd8e50c4660ea53cd377d86ea2c5a2b8.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e5d0756360240f552a30561d12abf62.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/354c73b8cdcee23bd9cd56b4e72f29b1.webp",980,1306]